Tandem Diabetes Care Announces First Quarter 2024 Financial ...

united states securities and exchange commission - Investor Relations

... Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results. and 2024 Financial Guidance. San Diego, February 21, 2024 ...

Tandem Diabetes Care to Announce Fourth Quarter and Full Year ...

SAN DIEGO--(BUSINESS WIRE)--Jan. 22, 2024-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology.

Tandem Diabetes Care and TypeZero Technologies Announce ...

"This agreement with TypeZero is a significant step in our shared vision to bring a best-in-class, closed-loop artificial pancreas system to the ...

10-K | iXBRL Viewer | Tandem Diabetes Care INC - Investor Relations

We currently rely on sales of insulin pump products to generate a significant portion of our revenue, and any factors that negatively impact sales of these ...

Tandem Diabetes Care Announces Proposed Private Placement of ...

4, 2024-- Tandem Diabetes Care, Inc. ... Tandem also intends to grant the initial purchasers of the notes an option to purchase, within the 13-day ...

Form 10-Q for Tandem Diabetes Care INC filed 05/02/2024

In particular, forward-looking statements contained in this Quarterly Report may relate to, among other things, our future or assumed financial ...

Tandem Diabetes Care Reports Third Quarter 2017 Financial Results

Tandem Diabetes Care Reports Third Quarter 2017 Financial Results · $23.7 million for the quarter ended September 30, 2017 compared to · $20.7 ...

Tandem Diabetes Care Announces Earlier Date for Q3 2016 ...

SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. ( NASDAQ : TNDM), a medical device company and manufacturer of the only ...

Tandem Diabetes Care Prices Upsized Private Placement of $275.0 ...

SAN DIEGO --(BUSINESS WIRE)--Mar. 6, 2024-- Tandem Diabetes Care, Inc. ... The offering was upsized from the previously announced offering size of ...

Form 8-K for Tandem Diabetes Care INC filed 03/11/2024

“Ex-Dividend Date” means the first date on which shares of the Common Stock trade on the applicable exchange or in the applicable market, ...

Tandem Diabetes Care Announces Approval of Reverse Stock Split

"The implementation of this reverse stock split will provide us with flexibility in our capital structure to pursue financing alternatives in ...

Tandem Diabetes Care Announces Commercial Launch of the t:slim ...

15, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its commercial ...

Form 8-K for Tandem Diabetes Care INC filed 02/22/2023

Tandem Diabetes Care Announces Fourth Quarter 2022 Financial Results and Full Year 2023 Financial Guidance ... Tandem Choice is December 31, 2024 ...

Tandem Diabetes Care Appoints New Chair of Board of Directors

(NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Rebecca Robertson as Chair of its ...

Tandem Diabetes Care Announces Pricing of $250.0 Million of ...

which the Notes are first issued, up to an additional $37.5 million aggregate principal amount of Notes. The sale of the Notes is expected ...

Form 10-Q for Tandem Diabetes Care INC filed 11/01/2023

See also “Trends and Uncertainties Impacting Financial Results—Product Launches ... fiscal quarter (the registrant's fourth fiscal quarter in the ...